Skip to main content
. Author manuscript; available in PMC: 2020 Nov 24.
Published in final edited form as: Curr Opin Virol. 2020 Oct 23;43:79–87. doi: 10.1016/j.coviro.2020.09.005

Table 2:

Infectivity of monovalent dengue vaccine candidates

Virus Dose (log10 PFU) No. subjects % viremic Mean peak virus titer log10 PFU/mL % seroconverting
rDEN1Δ30 3 71 61 1.0 93
rDEN2/4Δ30 3 40 60 0.5 100
rDEN2Δ30 3 10 100 2.5 100
rDEN3/4Δ30 3 20 15 1.0 30
rDEN3/4Δ30 4 20 0 n/a 25
rDEN3Δ30/31 3 50 34 0.5 81
rDEN3–3’D4Δ30 3 20 20 0.6 80
rDEN4Δ30 3 50 26 0.7 93
rDEN4Δ30–200,201 5 20 0 n/a 100
rDEN4Δ30–4995 5 20 0 n/a 95